MediCrops logo

MediCrops Holding AG


MediCrops Stock

MediCrops develops pharmaceuticals intended to offer medical cannabis preparations containing tetrahydrocannabinol (THC). The company cultivates cannabis under a state-approved cultivation license, offering a wide collection of premium recreational cannabis products, enabling the medical community to conduct a wide range of treatments.

Management Team

Ivan Mestrangelo Co-Founder, Co-Chief Executive Officer, and Chairman
Eva Vaoutsi Co-Chief Executive Officer
Luitpold Wüsthof Chief Financial Officer
Toby Shillito Chief Business Development Officer

Notable Investors

Funding Information